A study by consultants at Moorfields Eye Hospital has highlighted the benefits of Avastin injections over laser therapy in the treatment of diabetic macular oedema.
The results of the study showed improved vision for those treated with the injection and provided evidence for the longer-term use of bevacizumab in the treatment of persistent 'centre-involving clinically significant macular oedema'.
Half of a group of 80 patients with the condition were treated traditionally with laser, the other half with bevacizumab injections. The latter group showed improved vision which was maintained over the two-year period despite reduced injection frequency in the second year.
Robin Hamilton, consultant and clinical director of Moorfields Eye Hospital, said: 'Overall, the outcomes at this second stage are very encouraging and should be reassuring to physicians charged with delivering this relatively new treatment.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here